Literature DB >> 33991188

Studying the Utility of Using Genetics to Predict Smoking-Related Outcomes in a Population-Based Study and a Selected Cohort.

Michael J Bray1, Li-Shiun Chen1,2, Louis Fox1, Yinjiao Ma1, Richard A Grucza1, Sarah M Hartz1, Robert C Culverhouse3,4, Nancy L Saccone4,5, Dana B Hancock6, Eric O Johnson6,7, James D McKay8, Timothy B Baker9, Laura J Bierut1,2.   

Abstract

INTRODUCTION: The purpose of this study is to examine the predictive utility of polygenic risk scores (PRSs) for smoking behaviors. AIMS AND METHODS: Using summary statistics from the Sequencing Consortium of Alcohol and Nicotine use consortium, we generated PRSs of ever smoking, age of smoking initiation, cigarettes smoked per day, and smoking cessation for participants in the population-based Atherosclerosis Risk in Communities (ARIC) study (N = 8638), and the Collaborative Genetic Study of Nicotine Dependence (COGEND) (N = 1935). The outcomes were ever smoking, age of smoking initiation, heaviness of smoking, and smoking cessation.
RESULTS: In the European ancestry cohorts, each PRS was significantly associated with the corresponding smoking behavior outcome. In the ARIC cohort, the PRS z-score for ever smoking predicted smoking (odds ratio [OR]: 1.37; 95% confidence interval [CI]: 1.31, 1.43); the PRS z-score for age of smoking initiation was associated with age of smoking initiation (OR: 0.87; 95% CI: 0.82, 0.92); the PRS z-score for cigarettes per day was associated with heavier smoking (OR: 1.17; 95% CI: 1.11, 1.25); and the PRS z-score for smoking cessation predicted successful cessation (OR: 1.24; 95% CI: 1.17, 1.32). In the African ancestry cohort, the PRSs did not predict smoking behaviors.
CONCLUSIONS: Smoking-related PRSs were associated with smoking-related behaviors in European ancestry populations. This improvement in prediction is greatest in the lowest and highest genetic risk categories. The lack of prediction in African ancestry populations highlights the urgent need to increase diversity in research so that scientific advances can be applied to populations other than those of European ancestry. IMPLICATIONS: This study shows that including both genetic ancestry and PRSs in a single model increases the ability to predict smoking behaviors compared with the model including only demographic characteristics. This finding is observed for every smoking-related outcome. Even though adding genetics is more predictive, the demographics alone confer substantial and meaningful predictive power. However, with increasing work in PRSs, the predictive ability will continue to improve.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2021        PMID: 33991188      PMCID: PMC8570670          DOI: 10.1093/ntr/ntab100

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  25 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

Review 3.  Clinical use of current polygenic risk scores may exacerbate health disparities.

Authors:  Alicia R Martin; Masahiro Kanai; Yoichiro Kamatani; Yukinori Okada; Benjamin M Neale; Mark J Daly
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

4.  Dissection of the phenotypic and genotypic associations with nicotinic dependence.

Authors:  Li-Shiun Chen; Timothy B Baker; Richard Grucza; Jen C Wang; Eric O Johnson; Naomi Breslau; Dorothy Hatsukami; Stevens S Smith; Nancy Saccone; Scott Saccone; John P Rice; Alison M Goate; Laura J Bierut
Journal:  Nicotine Tob Res       Date:  2011-11-18       Impact factor: 4.244

5.  Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.

Authors:  Markus Aly; Fredrik Wiklund; Jianfeng Xu; William B Isaacs; Martin Eklund; Mauro D'Amato; Jan Adolfsson; Henrik Grönberg
Journal:  Eur Urol       Date:  2011-01-18       Impact factor: 20.096

Review 6.  The genetic epidemiology of smoking.

Authors:  P F Sullivan; K S Kendler
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

7.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

8.  Polygenic risk, rapid childhood growth, and the development of obesity: evidence from a 4-decade longitudinal study.

Authors:  Daniel W Belsky; Terrie E Moffitt; Renate Houts; Gary G Bennett; Andrea K Biddle; James A Blumenthal; James P Evans; Honalee Harrington; Karen Sugden; Benjamin Williams; Richie Poulton; Avshalom Caspi
Journal:  Arch Pediatr Adolesc Med       Date:  2012-06-01

9.  PRSice: Polygenic Risk Score software.

Authors:  Jack Euesden; Cathryn M Lewis; Paul F O'Reilly
Journal:  Bioinformatics       Date:  2014-12-29       Impact factor: 6.937

10.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

View more
  1 in total

1.  Drinking and smoking polygenic risk is associated with childhood and early-adulthood psychiatric and behavioral traits independently of substance use and psychiatric genetic risk.

Authors:  Flavio De Angelis; Frank R Wendt; Gita A Pathak; Daniel S Tylee; Aranyak Goswami; Joel Gelernter; Renato Polimanti
Journal:  Transl Psychiatry       Date:  2021-11-13       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.